These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results. Pulido JS; Winters JL; Boyer D Trans Am Ophthalmol Soc; 2006; 104():221-31. PubMed ID: 17471343 [TBL] [Abstract][Full Text] [Related]
6. Ranibizumab: new drug. Macular degeneration: second-line use due to risks. Prescrire Int; 2008 Feb; 17(93):3-6. PubMed ID: 18354841 [TBL] [Abstract][Full Text] [Related]
7. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292 [TBL] [Abstract][Full Text] [Related]
8. The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration. Gillies MC; Larsson J Am J Ophthalmol; 2007 Jul; 144(1):134-6. PubMed ID: 17601437 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic effects on retinal oxygen saturation, blood flow, and electrophysiological function in patients with neovascular age-related macular degeneration. Tsuchihashi T; Mori K; Peyman G; Shimada Y; Yoneya S Retina; 2009; 29(10):1450-6. PubMed ID: 19816240 [TBL] [Abstract][Full Text] [Related]
10. Macular microcirculation blood flow in patients with age related macular degeneration treated with photodynamic therapy and transpupillary thermotherapy. Kubicka-Trzaska A Klin Oczna; 2007; 109(4-6):138-41. PubMed ID: 17725271 [TBL] [Abstract][Full Text] [Related]